Skip to content

Health Literacy study

The role of health literacy in patients participating in clinical trials: a prospective analyse

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON25022
Enrollment
Unknown
Registered
2016-04-06
Start date
2015-12-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

health literacy, oncology, clinical trials, newest vital sign gezondheidsvaardigheden, oncologie, klinische studies, NVS Dutch

Interventions

N?A

Sponsors

Erasmus MC Cancer Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Patients >18 years - Patients with a end stage of cancer in good condition who consider oncology clinical trials participation

Exclusion criteria

Exclusion criteria: - Patients with a primairy braintumor or sympotomatic brainmetastases - not fluent in Dutch

Design outcomes

Primary

MeasureTime frame
Health literacy in patients considering oncology trial participation

Secondary

MeasureTime frame
Influence of health literacy on compliance

Contacts

Public ContactA.J. Biessen, van der

ErasmusMC Daniel Room G4-83 Groene Hilledijk 301

a.vanderbiessen@erasmusmc.nl+31 (0)10 7041132

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)